Assessment
nivolumab
Adjuvant treatment of muscle-invasive urothelial carcinoma (MIUC) with tumour cell PD-L1 expression >= 1% in adult patients with high recurrence risk after radical resection of MIUC
- Modules
- IQWiG assessments · G-BA decisions
- Connections
- 2
Connected evidence
2 relations